דעם כעלטקער לאַגער איז אַראָפּ מיט 30% אויף פרייטאג: דערקלערט דאָ

Tenet Healthcare Corp (NYSE: THC) crashed a 52-week low on Friday after reporting a weak Q3 and lowering its outlook for the full financial year.

Tenet to buyback shares

On the plus side, the healthcare services company announced a $1.0 billion share repurchase programme. In the פאַרדינסט דרוק מעלדונג, CEO Saum Sutaria said:

איר זוכט פֿאַר שנעל נייַעס, הייס עצות און מאַרק אַנאַליסיס? צייכן אַרויף פֿאַר די ינוועזז נוזלעטער.

Our business continues to generate strong free cash flow, enabling us to authorise a share repurchase programme that balances our uses of capital with investments to grow the business and debt retirement.

But investors seem to have discounted that authorisation.

The sell-off, though, might have created an attractive opportunity to ינוועסטירן אין דעם לאַגער considering the Wall Street has a consensus “buy” rating on it. The average price target on Tenet Healthcare Corp is $92 that represents more than a 100% upside from here.

Tenet Healthcare Q3 results

• ערנד $ 131 מיליאָן קעגן די יאָר צוריק $ 449 מיליאָן
• פאַרדינסט פּער שער איז שארף געפאלן פון $4.13 צו $1.16
• אויף אַ אַדזשאַסטיד יקער, ערנד $ 1.44 פּער שער
• רעוועך סליד 2.0% יאָר-צו-יאָר צו $ 4.80 ביליאָן
• קאָנסענסוס איז געווען $ 1.24 פּער שער אויף $ 4.81 ביליאָן רעוועך

Tenet Healthcare future outlook

For the full year, Tenet now forecasts $5.88 to $6.42 of adjusted EPS on $19 billion to $19.2 billion in revenue. In comparisons, analysts had called for $6.38 a share and $19.27 billion of revenue.

Its Q4 guidance was also below the Street expectations. CEO Sutaria also said:

During Q3, we worked to continue to recover from our cyberattack and dealt with a very active COVID spike among our employees, but the operating discipline across our business units allowed us to adapt to the environment.